SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001640455-23-000098
Filing Date
2023-05-04
Accepted
2023-05-04 07:26:18
Documents
2

Document Format Files

Seq Description Document Type Size
1 POS AM jnce05042023s-3posam.htm POS AM 36025
2 image_0.jpg GRAPHIC 89
  Complete submission text file 0001640455-23-000098.txt   37223
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-255760 | Film No.: 23886468
SIC: 2836 Biological Products, (No Diagnostic Substances)